Roche Holding | ROG - 贷款资金



金融业
股票价格
CHF 379.70
资产
CHF 98.2B
现金及等价物
CHF 7.55B
销售成本
CHF 7.85B
流动资产
CHF 35.44B
流动负债
CHF 28.85B
债务
CHF 33.03B
股息收益率
2.95
EBIT
CHF 11.47B
EBITDA
CHF 13.43B
员工
103.61K
EPS每股收益
CHF 10.98
股本和储备
CHF 32.69B
销售毛利
CHF 22.69B
债务利息支出
CHF 304M
贷款资金
CHF 25.22B
市值
CHF 258.34B
净收入
CHF 6.87B
营业费用
CHF 18.9B
营业利润
CHF 11.47B
普通股股本
CHF 796.77M
PE价格收益
16.48
税前利润
CHF 11.17B
销售收入
CHF 30.36B
销售和管理费用
CHF 6.37B
股票
CHF 7.6B
贸易债权人
CHF 5.54B
应收帐款人
CHF 13.34B


贷款资金 更改 日
AbbVie USD 64.53B 5.59B 2026-03
Alcon AG USD 4.65B 491M 2026-06
Almirall EUR 303.77M 21.04M 2026-06
Amgen USD 51.86B 27M 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Bayer EUR 31.16B 480M 2026-06
Biogen USD 7.29B 1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Fresenius EUR 9.55B 1.24B 2026-06
Fresenius Medical Care EUR 5.82B 83.04M 2026-06
Genmab DKK 4.96B 28M 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
GRIFOLS EUR 7.17B 1.91B 2026-06
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lakefront Biotherapeutics EUR 4.77M 78K 2026-06
Lonza CHF 3.88B 323M 2025-12
Merck EUR 11.21B 406M 2026-06
Merck USD 51.08B 4.41B 2026-06
Novartis USD 37.49B 42M 2026-06
Orion EUR 103.4M 7.2M 2026-06
Pfizer USD 60.5B 70M 2026-06
Philips EUR 6.32B 575M 2026-06
Recordati EUR 1.69B 67.09M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 14.65B 806M 2026-06
UCB EUR 2.18B 634M 2025-12